- Home
- AXSM vs TRNO Comparison
AXSM vs TRNO Comparison
Compare AXSM & TRNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- TRNO
- Stock Information
- Founded
- AXSM 2012
- TRNO 2009
- Country
- AXSM United States
- TRNO United States
- Employees
- AXSM N/A
- TRNO N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- TRNO Real Estate
- Sector
- AXSM Health Care
- TRNO Finance
- Exchange
- AXSM Nasdaq
- TRNO Nasdaq
- Market Cap
- AXSM 5.9B
- TRNO 6.0B
- IPO Year
- AXSM 2015
- TRNO 2010
- Fundamental
- Price
- AXSM $118.87
- TRNO $58.01
- Analyst Decision
- AXSM Strong Buy
- TRNO Buy
- Analyst Count
- AXSM 19
- TRNO 10
- Target Price
- AXSM $174.26
- TRNO $65.00
- AVG Volume (30 Days)
- AXSM 472.4K
- TRNO 661.3K
- Earning Date
- AXSM 11-03-2025
- TRNO 11-05-2025
- Dividend Yield
- AXSM N/A
- TRNO 3.56%
- EPS Growth
- AXSM N/A
- TRNO 40.84
- EPS
- AXSM N/A
- TRNO 2.52
- Revenue
- AXSM $495,033,000.00
- TRNO $425,998,000.00
- Revenue This Year
- AXSM $63.62
- TRNO $21.56
- Revenue Next Year
- AXSM $55.72
- TRNO $10.82
- P/E Ratio
- AXSM N/A
- TRNO $23.14
- Revenue Growth
- AXSM 69.83
- TRNO 22.17
- 52 Week Low
- AXSM $75.56
- TRNO $48.18
- 52 Week High
- AXSM $139.13
- TRNO $69.20
- Technical
- Relative Strength Index (RSI)
- AXSM 53.69
- TRNO 50.11
- Support Level
- AXSM $117.50
- TRNO $57.78
- Resistance Level
- AXSM $122.14
- TRNO $59.00
- Average True Range (ATR)
- AXSM 2.97
- TRNO 1.01
- MACD
- AXSM -0.29
- TRNO -0.07
- Stochastic Oscillator
- AXSM 44.79
- TRNO 34.16
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About TRNO Terreno Realty Corporation
Terreno Realty Corp is a real estate investment trust engaged in acquiring, owning, and operating industrial real estate in six coastal U.S. markets: Los Angeles, Northern New Jersey/New York City, San Francisco Bay Area, Seattle, Miami, and Washington, D.C. The company invests in several types of industrial real estate, including warehouse/distribution, flex (including light industrial and research and development), transshipment, and improved land.